{"meta":{"query_hash":"42d030c66fa6","filters":{"venue":"Journal of Korean Pharmaceutical Sciences"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/42d030c66fa6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Korean+Pharmaceutical+Sciences"},"results":[{"id":"W2310631813","doi":"","title":"미국과 캐나다의 의약품 허가-특허 연계제도","year":2008,"lang":"ko","type":"article","venue":"Journal of Korean Pharmaceutical Sciences","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Notice; Business; Patent infringement; Linkage (software); Generic drug; Product (mathematics); Certification; Expiration date; Listing (finance); Actuarial science; Marketing; Accounting; Drug; Law; Intellectual property; Finance; Medicine; Political science; Pharmacology","score_opus":0.2985697480170249,"score_gpt":0.3299346235415387,"score_spread":0.03136487552451378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2310631813","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018441506,0.0032830818,0.016611278,0.014046918,0.001295998,0.000630809,0.00059664,0.0004208842,0.9446728],"genre_scores_gemma":[0.3396525,0.004085558,0.022407942,0.013117192,0.00029769915,0.00032331384,0.00090071006,0.00013400742,0.61908096],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99464697,0.000947717,0.00029881677,0.00070468057,0.0025326693,0.00086909364],"domain_scores_gemma":[0.9962931,0.00057007803,0.0003242617,0.00035097278,0.00217113,0.00029040087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030302613,0.00035119746,0.00022454115,0.0011541514,0.004517682,0.0059205387,0.0009873563,0.00187036,0.023482308],"category_scores_gemma":[0.0048704273,0.00028024463,0.0005638852,0.0016707638,0.0036442084,0.0030306517,0.0022512528,0.002172367,0.011915678],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000714585,0.00013451565,0.00855204,0.00042620915,0.000019820216,0.00064036704,0.0061044134,0.00051409024,0.002505717,0.5800546,0.16272885,0.23824798],"study_design_scores_gemma":[0.000011417222,0.00007042555,0.005630316,0.00016632592,0.000018059318,0.00040750593,0.0023200284,0.00033114693,0.0027756568,0.015280315,0.9729485,0.000040307612],"about_ca_topic_score_codex":0.068576485,"about_ca_topic_score_gemma":0.07625315,"teacher_disagreement_score":0.93142354,"about_ca_system_score_codex":0.0063375947,"about_ca_system_score_gemma":0.016812306,"threshold_uncertainty_score":0.13635463},"labels":[],"label_agreement":null}]}